Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
HCC After DAAs Requires More Study, but no Cause for Withheld Treatment
As we continue to see the success of direct-acting antiviral therapy in treating hepatitis C virus, we must be aware of any potential complications from the underlying liver disease after successful treatment, especially hepatocellular carcinoma.
HCV-Positive, Recipient-Negative Transplant Solves Problems, Raises Questions
From its inception, the concept of organ transplantation has drilled down to the fundamental ethics of practicing medicine. From initial concerns about donating organs from individuals who died of a cardiac event to the advent of living donation, the medical community questioned if this practice violates the basic tenet of the Hippocratic Oath: do no harm. Now the HCV community is moving steadily toward donation of HCV-positive organs into HCV-negative recipients, and a new set of questions arises.
Log in or Sign up for Free to view tailored content for your specialty!
FDA Approves DAAs for Pediatric Patients with HCV
The FDA has approved sofosbuvir and ledipasvir/sofosbuvir as supplemental applications for the treatment of hepatitis C in children aged 12 to 17 years, according to an FDA news release.
Nurse response time to alarms varies based on intuition
Responses to physiologic monitor alarms in children’s hospitals are affected by multiple factors, including the length of time spent working, the severity of the condition, nurse-to-patient ratio, and physical and mental fatigue, according to research published in JAMA Pediatrics.
CMS proposes 2018 Medicare payment, policy updates for hospital admissions
CMS issued a proposed rule to update 2018 Medicare payment and policies for patients admitted into the hospital, according to a press release. The rule seeks to relieve regulatory burdens for providers, support patient-doctor relationships and encourage transparency, flexibility and innovation to transform the health care delivery system and the Medicare program.
CMS issues final rule on health insurance market for 2018
To provide some immediate relief for patients and insurers, CMS has issued the final Market Stabilization Rule, which the agency says will help lower premiums, stabilize individual and small group markets and increase health care choices.
2D shear wave elastography offers noninvasive evaluation of fibrosis
Researchers found 2D shear wave elastography had good to excellent efficiency for evaluating liver fibrosis in patients, particularly those with hepatitis B, according to a recently published study.
Healio.com celebrates 5th anniversary
THOROFARE, N.J. – Healio.com, a clinical news and education website for health care professionals in more than 25 specialties, celebrates its 5-year anniversary this month.
AAFP, AMA, others implore Trump, Congress to stabilize individual health insurance market
Representatives of AMA, AAFP and several other associations recently sent President Donald J. Trump and leaders of the U.S. House and Senate letters urging them to continue funding cost sharing reductions for health care and stabilize the individual health insurance market.
Report: ‘Deliberate steps’ required to preserve, foster integrity in scientific research
The U.S. scientific research enterprise must improve its practices and policies to protect the integrity of research, according to a report from the National Academies of Sciences, Engineering, and Medicine.
-
Headline News
Q&A: 1 in 5 COVID-19 deaths due to strain of hospital overcrowding
September 25, 20244 min read -
Headline News
Impact of Dobbs ‘immediate and profound’ on OB/GYN residents in Wisconsin
September 25, 20246 min read -
Headline News
FDA approves second Niemann-Pick disease type C treatment
September 25, 20241 min read
-
Headline News
Q&A: 1 in 5 COVID-19 deaths due to strain of hospital overcrowding
September 25, 20244 min read -
Headline News
Impact of Dobbs ‘immediate and profound’ on OB/GYN residents in Wisconsin
September 25, 20246 min read -
Headline News
FDA approves second Niemann-Pick disease type C treatment
September 25, 20241 min read